2024

  • ALA-3000 has received a notice of patent allowance from National Office of Intellectual Property of Vietnam (NOIP) on March 14, Application No. 1-2021-03276
  • ALA-1300 has received a notice of patent allowance from Taiwan Intellectual Property Office (TIPO) on March 07, Application No. 108116576
  • ALA-3000 has received a notice of patent allowance from United States Patent and Trademark Office (USPTO) on February 22, Application No. 17/421,407
  • ALA-3000 has received a notice of patent allowance from Japan Patent Office (JPO) on February 22, Application No. 2021-540341
  • ALA-3000 has received a notice of patent allowance from Mexican Institute of Industrial Property (IMPI) on February 19, Application No. 2021006029
  • ALA-2000 has received a notice of patent allowance from The Office of the Controller General of Patents, Designs and Trade Marks (CGPDTM), India, on February 05, Application No. 501360

2023

  • ALA-1300 has received a notice of patent allowance from Japan Patent Office (JPO) on December 19, Application No. 2020-561817
  • ALA-3000 has  received a notice of patent allowance from Taiwan Intellectual Property Office (TIPO) on November 13, Application No. 109100921
  • ALA-2000 has  received a notice of patent allowance from Taiwan Intellectual Property Office (TIPO) on October 12, Application No. 108147847
  • ALA-2000 has  received a notice of patent allowance from Russian Patent and Trademark Office (PUPTO) on October 12, Application No. 2021114222
  • ALA-1300 has received a notice of patent allowance from The National Office of Intellectual Property of Vietnam (NOIP) on September 27, Application No. 1-2020-06145)
  • ALA-3000 has received a notice of patent allowance from Intellectual Property Office of Singapore (IPOS) on August 21, Application No. 11202104792S
  • ALA-1300 has received a notice of patent allowance from China National Intellectual Property Administration (CNIPA) on August 10, Application No. 201980023678.2
  • ALA-1300 has received a notice of patent allowance from Intellectual Property Office of New Zealand (IPONZ) on August 10, Application No. 766474
  • ALA-3000 has received a notice of patent allowance from National Institute of Industrial Property Institute (INAPI), Chile, on August 07, Application No. 202101803
  • ALA-3000 has received a notice of patent allowance from European Patent Office (EPO) on August 02, Application No. 20739053.5
  • ALA-3000 has received a notice of patent allowance from China National Intellectual Property Administration (CNIPA) on July 25, Application No. 202080007207.5
  • ALA-1300 has received a notice of patent allowance from Directorate General of Intellectual Property Rights (DGIP), Indonesia, on July 19, Application No. IDP 000 087828 B
  • ALA-1000 has received a notice of patent allowance from The Intellectual Property Corporation of Malaysia (MyIPO) on June 29, Application No. MY-196269-A
  • ALA-2000 has received a notice of patent allowance from China National Intellectual Property Administration (CNIPA) on April 06, Application No. 201980085067.0
  • ALA-1300 has received a notice of patent allowance from Australian Patent Office (IP Australia) on February 01, Application No. PCT/CN2019/086449

2022

  • ALA-1300 received notice of patient allowance from Mexican Institute of Industrial Property (IMPI) on December 29, Application No. MX/a/2020/008471
  • ALA-1300 received notice of patient allowance from South Africa-Companies and Intellectual Property Commission (CIPC) on December 05, Application No. 2020/04582
  • ALA-1000 received notice of patient allowance from China National Intellectual Property Administration (CNIPA) on November 21, Application No. 201780055635.3
  • ALA-1000 received notice of patent allowance from National Institute of Industrial Property Institute (INAPI), Chile on August 10, Application No. 624-2019 
  • ALA-1000 received notice of patent allowance from  European Patent Office (EPO) on May 12 , Application No. 17850245.6
  • ALA-1000 received notice of patent allowance from Director de Invenciones y Nuevas Tecnologías INDECOPI on May 12, Application No. 000487-2019/DIN
  • ALA-1000 received notice of patent allowance from Intellectual Property Office of India on May 6, Application No. 201947006642
  • ALA-1000 received notice of patent allowance from Intellectual Property Office of Singapore (IPOS) on April 21, Application No. 11201901294Q
  • Alar announces Significant Progress on Developing long-acting Buprenorphine
    Injectable ALA-1000 on January 13

2021

  • ALA-1000 received notice of patent allowance from Directorate General of Intellectual Property (DGIP) of Indonesia on November 30, Application No. P00201902139
  • Alar announced results from ALA-1000 Single Ascending Dose Study in Opioid Dependent Patients on November 9
  • ALA-1000 received notice of patent allowance from Intellectual Property Office of Vietnam on October 29, Application No. 1-2019-01258
  • Successful End-of-Phase 2 Meeting with US FDA for ALA-1000 for the Treatment of Opioid Use Disorder on October 28
  • ALA-1000 received notice of patent allowance from Taiwan Intellectual Property Office (TIPO) on September 3, Application No. 106131215
  • ALA-1000 received notice of patent allowance from South Africa-Companies and Intellectual Property Commission Department of Trade and Industry (CIPC) on August 25, Application No. 201900890
  • ALA-1000 received notice of patent allowance from Japan Patent Office (JPO) on August 3,  Application No. 特願2019-535434
  • ALA-1000 received notice of patent allowance from Innovation, Science and Economic Development Canada (ISED) on May 10, Application No.3,033,046
  • ALA-1000 received notice of patent allowance from the IP New Zealand on April 30. Application No. 750367
  • ALA-1000 received notice of allowance for patent registration from Korean Intellectual Property Office on April 16, Application No. 10-2019-7009185
  • ALA-1000 received Decision of Grant from Federal Service for Intellectual Property (ROSPATENT) on April 12, Application No. 2019102895

2020

  • Listed on Taipei Exchange Market in Taiwan on September 23. Traded on October 5
  • ALA-1000 received notice of patent allowance from the IP Australia
  • ALA-3000 completed pre-IND Meeting with US FDA
  • ALA-1000 received notice of patent allowance from the Mexican Institute of Industrial Property (IMPI)
  • Approved to be a public offering company on June 3.  Stock Code: 6785
  • ALA-1000 received notice of patent allowance from USPTO
  • ALA-1000 was approved by Ministry of Economic Affairs : A+ Industrial Innovation R&D Program (fast track)

2019

  • Approved by the Ministry of Economic Affairs as a Biotech Pharmaceutical company

  • ALA-1000 received US FDA IND approval

  • Approved to be located in Central Science Park

2017

  • ALA-1000 was approved by Ministry of Economic Affairs:A+ Industrial Innovation R&D Program-Industrial Technology Foresight Research Program

2016

  • Alar Pharmaceuticals Inc. was founded